Fig. 6 | Signal Transduction and Targeted Therapy

Fig. 6

From: Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

Fig. 6

Role of Tissue Macrophages in Diseases. In neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, macrophages are implicated in neuronal damage and neurotoxicity, involving the processing of amyloid-beta and alpha-synuclein. In metabolic disorders like obesity, which represents a state of systemic chronic inflammation, macrophages accelerate the development of insulin resistance and affect the efficacy of cell-based immunotherapies through tumor-associated macrophage interactions. Additionally, the diverse functions of macrophages are also evident in the progression of hepatic diseases, including hepatitis, liver cirrhosis, and hepatocellular carcinoma. p-Tau phosphorylated tau, APP amyloid precursor protein, SAPPβ soluble amyloid precursor protein beta, TREM2 triggering receptor expressed on myeloid cells 2, LRRK2 leucine-rich repeat kinase 2, NADPH nicotinamide adenine dinucleotide phosphate (reduced form), NOTCH NOTCH signaling pathway, mTOR1 mechanistic target of rapamycin complex 1, P53 tumor protein p53, CXCL10 C-X-C motif chemokine ligand 10, LGALS3 galectin-3 TNFsf12 tumor necrosis factor superfamily member 12

Back to article page